Literature DB >> 26715171

Endocervical adenocarcinoma: selected diagnostic challenges.

Brigitte M Ronnett1.   

Abstract

Endocervical adenocarcinomas can be classified into two main types of tumors, namely, those related to high-risk human papillomavirus and those unrelated to high-risk human papillomavirus. The former, representing the vast majority, are referred to as endocervical adenocarcinomas of usual type and the latter are dominated by the gastric-type mucinous adenocarcinomas. Commonly encountered diagnostic problems concerning these endocervical adenocarcinomas include: (1) diagnosing invasion for endocervical adenocarcinomas of usual type, particularly superficial forms which must be distinguished from extensive endocervical adenocarcinoma in situ; (2) distinguishing high-risk human papillomavirus-related endocervical adenocarcinomas from endometrial endometrioid carcinomas; and (3) distinguishing benign/hyperplastic mucinous endocervical glandular proliferations from gastric-type mucinous endocervical adenocarcinomas, particularly minimal deviation adenocarcinoma. The current review provides practical points and numerous illustrative examples to guide pathologists in addressing these diagnostic challenges in routine practice.

Entities:  

Mesh:

Year:  2016        PMID: 26715171     DOI: 10.1038/modpathol.2015.131

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  19 in total

1.  Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.

Authors:  E C Pirog; B Kleter; S Olgac; P Bobkiewicz; J Lindeman; W G Quint; R M Richart; C Isacson
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Diffuse laminar endocervical glandular hyperplasia. A benign lesion often confused with adenoma malignum (minimal deviation adenocarcinoma).

Authors:  M A Jones; R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1991-12       Impact factor: 6.394

3.  Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum.

Authors:  M R Nucci; P B Clement; R H Young
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

4.  Invasive endocervical adenocarcinoma: proposal for a new pattern-based classification system with significant clinical implications: a multi-institutional study.

Authors:  Andrea Diaz De Vivar; Andres A Roma; Kay J Park; Isabel Alvarado-Cabrero; Golnar Rasty; Jose G Chanona-Vilchis; Yoshiki Mikami; Sung R Hong; Brent Arville; Norihiro Teramoto; Rouba Ali-Fehmi; Joanne K L Rutgers; Farah Tabassum; Denise Barbuto; Irene Aguilera-Barrantes; Alexandra Shaye-Brown; Dean Daya; Elvio G Silva
Journal:  Int J Gynecol Pathol       Date:  2013-11       Impact factor: 2.762

5.  Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype.

Authors:  Yasuki Kusanagi; Atsumi Kojima; Yoshiki Mikami; Takako Kiyokawa; Tamotsu Sudo; Satoshi Yamaguchi; Ryuichiro Nishimura
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

6.  Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.

Authors:  Anna Yemelyanova; Russell Vang; Jeffrey D Seidman; Patti E Gravitt; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2009-06       Impact factor: 6.394

Review 7.  Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis.

Authors:  R H Young; P B Clement
Journal:  Histopathology       Date:  2002-09       Impact factor: 5.087

8.  Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.

Authors:  Anna Yemelyanova; Hongxiu Ji; Ie-Ming Shih; Tian-Li Wang; Lee-Shu-Fune Wu; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

9.  Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases.

Authors:  C B Gilks; R H Young; P Aguirre; R A DeLellis; R E Scully
Journal:  Am J Surg Pathol       Date:  1989-09       Impact factor: 6.394

Review 10.  New developments in endocervical glandular lesions.

Authors:  W Glenn McCluggage
Journal:  Histopathology       Date:  2012-11-08       Impact factor: 5.087

View more
  8 in total

1.  Micropapillary Cervical Adenocarcinoma: A Clinicopathologic Study of 44 Cases.

Authors:  Isabel Alvarado-Cabrero; W Glenn McCluggage; Rafael Estevez-Castro; Delia Pérez-Montiel; Simona Stolnicu; Raji Ganesan; Josefa Vella; Rosario Castro; Javier Canedo-Matute; Jessica Gomez-Cifuentes; Vilma M Rivas-Lemus; Kay J Park; Robert A Soslow; Esther Oliva; Raquel Valencia-Cedillo
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

2.  Morphologic Features of Gastric-type Cervical Adenocarcinoma in Small Surgical and Cytology Specimens.

Authors:  Gulisa Turashvili; Elizabeth G Morency; Mihaela Kracun; Deborah F DeLair; Sarah Chiang; Robert A Soslow; Kay J Park; Rajmohan Murali
Journal:  Int J Gynecol Pathol       Date:  2019-05       Impact factor: 2.762

3.  CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.

Authors:  Fenne L Komdeur; Thalina M Prins; Stephanie van de Wall; Annechien Plat; G Bea A Wisman; Harry Hollema; Toos Daemen; David N Church; Marco de Bruyn; Hans W Nijman
Journal:  Oncoimmunology       Date:  2017-07-24       Impact factor: 8.110

4.  The Silva Pattern-based Classification for HPV-associated Invasive Endocervical Adenocarcinoma and the Distinction Between In Situ and Invasive Adenocarcinoma: Relevant Issues and Recommendations From the International Society of Gynecological Pathologists.

Authors:  Isabel Alvarado-Cabrero; Carlos Parra-Herran; Simona Stolnicu; Andres Roma; Esther Oliva; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

5.  LncRNAs specifically overexpressed in endocervical adenocarcinoma are associated with an unfavorable recurrence prognosis and the immune response.

Authors:  Yong Song; Long Nie; Yu-Ting Zhang
Journal:  PeerJ       Date:  2021-09-21       Impact factor: 2.984

6.  Tumor histology is an independent prognostic factor in locally advanced cervical carcinoma: A retrospective study.

Authors:  Lenny Gallardo-Alvarado; David Cantú-de León; Rebeca Ramirez-Morales; Gabriel Santiago-Concha; Salim Barquet-Muñoz; Rosa Salcedo-Hernandez; Cinthya Reyes; Sandra Perez-Alvarez; Delia Perez-Montiel; Carlos Perez-Plasencia; Elizabeth Trejo-Duran; Juan Pablo Galicia
Journal:  BMC Cancer       Date:  2022-04-13       Impact factor: 4.430

7.  Coexistence of gastric choriocarcinoma and adenocarcinoma with reproductive hormone secretion in a man: a case report.

Authors:  Lei Chen; Xin Yi; Hong-Li Zou; Xu-An Chen; Shang Gao; Pei-Hai Zhang
Journal:  J Int Med Res       Date:  2020-03       Impact factor: 1.671

8.  A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.

Authors:  Anna Radomska; Daniel Lee; Heather Neufeld; Nancy Korte; Emina Torlakovic; Anita Agrawal; Rajni Chibbar
Journal:  Diagn Pathol       Date:  2021-07-31       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.